Quick Answer
PALISADE BIO, INC. reported Long-Term Debt of $0.00 for fiscal year 2021.
PALISADE BIO, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2021 | $0.00 | -100.0% |
| 2020 | $94.0K | -97.2% |
| 2015 | $3.38M | -58.0% |
| 2014 | $8.06M | +63.3% |
| 2013 | $4.93M | — |
| 2012 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $0.00 | — | — |
| June 30, 2021 | $0.00 | — | -100.0% |
| December 31, 2020 | $94.0K | — | -96.3% |
| March 31, 2016 | $2.55M | -63.4% | -24.7% |
| December 31, 2015 | $3.38M | -58.0% | -26.9% |
| September 30, 2015 | $4.63M | +77.1% | -20.4% |
| June 30, 2015 | $5.81M | +70.2% | -16.4% |
| March 31, 2015 | $6.95M | +65.9% | -13.7% |
- PALISADE BIO, INC. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from PALISADE BIO, INC.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 17, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: